TL1A induces the expression of TGF-β-inducible gene h3 (βig-h3) through PKC, PI3K, and ERK in THP-1 cells

Cellular Immunology

Volumn 266, Issue 1, 2010, Pages 61-66

  Lee, Seung Hee ^a   Kim, Eun Ju ^a   Suk, Kyoungho ^a   Kim, In San ^b   Lee, Won Ha ^a  

^a Kyungpook National University   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

Author keywords

ig h3; Extra cellular matrix; Inflammation; Macrophage; TNFSF

Indexed keywords

HUMAN MONOCLONAL ANTIBODY; I KAPPA B; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; TUMOR NECROSIS FACTOR LIKE LIGAND 1A; UNCLASSIFIED DRUG;

ARTICLE; BETA INDUCIBLE GENE H3; CELL ACTIVATION; CELL STIMULATION; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LEUKEMIA CELL LINE; MACROPHAGE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; WESTERN BLOTTING;

ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; ENZYME INHIBITORS; EXTRACELLULAR MATRIX PROTEINS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION; HUMANS; MONOCYTES; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 25; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15;

EID: 77958488630     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2010.08.013     Document Type: Article

References (31)

1. Chinnaiyan A.M., O'Rourke K., Yu G.L., Lyons R.H., Garg M., Duan D.R., Xing L., Gentz R., Ni J., Dixit V.M. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 1996, 274:990-992.
2. Bull M.J., Williams A.S., Mecklenburgh Z., Calder C.J., Twohig J.P., Elford C., Evans B.A., Rowley T.F., Slebioda T.J., Taraban V.Y., Al-Shamkhani A., Wang E.C. The death receptor 3-TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis. J. Exp. Med. 2008, 205:2457-2464.
3. Kang Y.J., Kim W.J., Bae H.U., Kim D.I., Park Y.B., Park J.E., Kwon B.S., Lee W.H. Involvement of TL1A and DR3 in induction of pro-inflammatory cytokines and matrix metalloproteinase-9 in atherogenesis. Cytokine 2005, 29:229-235.
4. Wang E.C., Thern A., Denzel A., Kitson J., Farrow S.N., Owen M.J. DR3 regulates negative selection during thymocyte development. Mol. Cell. Biol. 2001, 21:3451-3461.
5. Migone T.S., Zhang J., Luo X., Zhuang L., Chen C., Hu B., Hong J.S., Perry J.W., Chen S.F., Zhou J.X., Cho Y.H., Ullrich S., Kanakaraj P., Carrell J., Boyd E., Olsen H.S., Hu G., Pukac L., Liu D., Ni J., Kim S., Gentz R., Feng P., Moore P.A., Ruben S.M., Wei P. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 2002, 16:479-492.
6. Meylan F., Davidson T.S., Kahle E., Kinder M., Acharya K., Jankovic D., Bundoc V., Hodges M., Shevach E.M., Keane-Myers A., Wang E.C., Siegel R.M. The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases. Immunity 2008, 29:79-89.
7. Bamias G., Martin C., Marini M., Hoang S., Mishina M., Ross W.G., Sachedina M.A., Friel C.M., Mize J., Bickston S.J., Pizarro T.T., Wei P., Cominelli F. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease. J. Immunol. 2003, 171:4868-4874.
8. Gibson M.A., Kumaratilake J.S., Cleary E.G. Immunohistochemical and ultrastructural localization of MP78/70 (βig-h3) in extracellular matrix of developing and mature bovine tissues. J. Histochem. Cytochem. 1997, 45:1683-1696.
9. Hashimoto K., Noshiro M., Ohno S., Kawamoto T., Satakeda H., Akagawa Y., Nakashima K., Okimura A., Ishida H., Okamoto T., Pan H., Shen M., Yan W., Kato Y. Characterization of a cartilage-derived 66-kDa protein (RGD-CAP/βig-h3) that binds to collagen. Biochim. Biophys. Acta 1997, 1355:303-314.
10. Munier F.L., Korvatska E., Djemai A., Le Paslier D., Zografos L., Pescia G., Schorderet D.F. Kerato-epithelin mutations in four 5q31-linked corneal dystrophies. Nat. Genet. 1997, 15:247-251.
11. Skonier J., Neubauer M., Madisen L., Bennett K., Plowman G.D., Purchio A.F. CDNA cloning and sequence analysis of βig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-β DNA Cell Biol. 1992, 11:511-522.
12. Hanssen E., Reinboth B., Gibson M.A. Covalent and non-covalent interactions of βig-h3 with collagen VI βig-h3 is covalently attached to the amino-terminal region of collagen VI in tissue microfibrils. J. Biol. Chem. 2003, 278:24334-24341.
13. Billings P.C., Whitbeck J.C., Adams C.S., Abrams W.R., Cohen A.J., Engelsberg B.N., Howard P.S., Rosenbloom J. The transforming growth factor-β-inducible matrix protein (β)ig-h3 interacts with fibronectin. J. Biol. Chem. 2002, 277:28003-28009.
14. Kim H.J., Kim I.S. Transforming growth factor-β-induced gene product, as a novel ligand of integrin αMβ2, promotes monocytes adhesion, migration and chemotaxis. Int. J. Biochem. Cell Biol. 2008, 40:991-1004.
15. Thapa N., Lee B.H., Kim I.S. TGFBIp/βig-h3 protein: a versatile matrix molecule induced by TGF-β Int. J. Biochem. Cell Biol. 2007, 39:2183-2194.
16. Ha S.W., Bae J.S., Yeo H.J., Lee S.H., Choi J.Y., Sohn Y.K., Kim J.G., Kim I.S., Kim B.W. TGF-β-induced protein βig-h3 is upregulated by high glucose in vascular smooth muscle cells. J. Cell. Biochem. 2003, 88:774-782.
17. Li C., Lim S.W., Choi B.S., Lee S.H., Cha J.H., Kim I.S., Kim J., Yang C.W. Inhibitory effect of pravastatin on transforming growth factor β1-inducible gene h3 expression in a rat model of chronic cyclosporine nephropathy. Am. J. Nephrol. 2005, 25:611-620.
18. Nam E.J., Sa K.H., You D.W., Cho J.H., Seo J.S., Han S.W., Park J.Y., Kim S.I., Kyung H.S., Kim I.S., Kang Y.M. Up-regulated transforming growth factor β-inducible gene h3 in rheumatoid arthritis mediates adhesion and migration of synoviocytes through α v β3 integrin: regulation by cytokines. Arthritis Rheum. 2006, 54:2734-2744.
19. O'Brien E.R., Bennett K.L., Garvin M.R., Zderic T.W., Hinohara T., Simpson J.B., Kimura T., Nobuyoshi M., Mizgala H., Purchio A., Schwartz S.M βig-h3, a transforming growth factor-β-inducible gene, is overexpressed in atherosclerotic and restenotic human vascular lesions. Arterioscler. Thromb. Vasc. Biol. 1996, 16:576-584.
20. Yun S.J., Kim M.O., Kim S.O., Park J., Kwon Y.K., Kim I.S., Lee E.H. Induction of TGF-β-inducible gene-h3 (βig-h3) by TGF-β1 in astrocytes: implications for astrocyte response to brain injury. Brain Res. Mol. Brain Res. 2002, 107:57-64.
21. Lee S.H., Bae J.S., Park S.H., Lee B.H., Park R.W., Choi J.Y., Park J.Y., Ha S.W., Kim Y.L., Kwon T.H., Kim I.S. Expression of TGF-β-induced matrix protein βig-h3 is up-regulated in the diabetic rat kidney and human proximal tubular epithelial cells treated with high glucose. Kidney Int. 2003, 64:1012-1021.
22. Rosenau C., Emery D., Kaboord B., Qoronfleh M.W. Development of a high-throughput plate-based chemiluminescent transcription factor assay. J. Biomol. Screen. 2004, 9:334-342.
23. Bae E.M., Kim W.J., Suk K., Kang Y.M., Park J.E., Kim W.Y., Choi E.M., Choi B.K., Kwon B.S., Lee W.H. Reverse signaling initiated from GITRL induces NF-κB activation through ERK in the inflammatory activation of macrophages. Mol. Immunol. 2008, 45:523-533.
24. Han Y., Englert J.A., Yang R., Delude R.L., Fink M.P. Ethyl pyruvate inhibits nuclear factor-κB-dependent signaling by directly targeting p65. J. Pharmacol. Exp. Ther. 2005, 312:1097-1105.
25. Jeon S.T., Kim W.J., Lee S.M., Lee M.Y., Park S.B., Lee S.H., Kim I.S., Suk K., Choi B.K., Choi E.M., Kwon B.S., Lee W.H. Reverse signaling through BAFF differentially regulates the expression of inflammatory mediators and cytoskeletal movements in THP-1 cells. Immunol. Cell Biol. 2010, 88:148-156.
26. Requena P., Daddaoua A., Guadix E., Zarzuelo A., Suarez M.D., Sanchez de Medina F., Martinez-Augustin O. Bovine glycomacropeptide induces cytokine production in human monocytes through the stimulation of the MAPK and the NF-κB signal transduction pathways. Br. J. Pharmacol. 2009, 157:1232-1240.
27. Yang Y., Lu N., Zhou J., Chen Z.N., Zhu P. Cyclophilin A up-regulates MMP-9 expression and adhesion of monocytes/macrophages via CD147 signalling pathway in rheumatoid arthritis. Rheumatology (Oxford) 2008, 47:1299-1310.
28. Song C., Hsu K., Yamen E., Yan W., Fock J., Witting P.K., Geczy C.L., Freedman S.B. Serum amyloid A induction of cytokines in monocytes/macrophages and lymphocytes. Atherosclerosis 2009, 207:374-383.
29. Gaurnier-Hausser A., Rothman V.L., Dimitrov S., Tuszynski G.P. The novel angiogenic inhibitor, angiocidin, induces differentiation of monocytes to macrophages. Cancer Res. 2008, 68:5905-5914.
30. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 1999, 340:115-126.
31. Kim S.H., Lee W.H., Kwon B.S., Oh G.T., Choi Y.H., Park J.E. Tumor necrosis factor receptor superfamily 12 may destabilize atherosclerotic plaques by inducing matrix metalloproteinases. Jpn. Circ. J. 2001, 65:136-138.